1. Home
  2. VIRC vs PYPD Comparison

VIRC vs PYPD Comparison

Compare VIRC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.27

Market Cap

99.1M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.97

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
PYPD
Founded
1950
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.1M
85.1M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
VIRC
PYPD
Price
$6.27
$4.97
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$7.30
$12.25
AVG Volume (30 Days)
120.4K
155.6K
Earning Date
04-08-2026
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$199,652,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.16
$3.06
52 Week High
$9.07
$5.24

Technical Indicators

Market Signals
Indicator
VIRC
PYPD
Relative Strength Index (RSI) 53.22 56.87
Support Level $5.99 $4.18
Resistance Level $6.50 $5.09
Average True Range (ATR) 0.34 0.27
MACD 0.01 0.03
Stochastic Oscillator 38.82 70.27

Price Performance

Historical Comparison
VIRC
PYPD

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: